Cargando…
Trimethylguanosine synthase 1 is a novel regulator of pancreatic beta-cell mass and function
Type 2 diabetes is a metabolic disorder associated with abnormal glucose homeostasis and is characterized by intrinsic defects in β-cell function and mass. Trimethylguanosine synthase 1 (TGS1) is an evolutionarily conserved enzyme that methylates small nuclear and nucleolar RNAs and that is involved...
Autores principales: | Blandino-Rosano, Manuel, Romaguera Llacer, Pau, Lin, Ashley, Reddy, Janardan K., Bernal-Mizrachi, Ernesto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861161/ https://www.ncbi.nlm.nih.gov/pubmed/35041827 http://dx.doi.org/10.1016/j.jbc.2022.101592 |
Ejemplares similares
-
Role of nutrients and mTOR signaling in the regulation of pancreatic progenitors development
por: Elghazi, Lynda, et al.
Publicado: (2017) -
A Trimethylguanosine Synthase1-like (TGS1) homologue is implicated in vernalisation and flowering time control
por: Taylor, Candy M., et al.
Publicado: (2021) -
Overexpression of Kinase-Dead mTOR Impairs Glucose Homeostasis by Regulating Insulin Secretion and Not β-Cell Mass
por: Alejandro, Emilyn U., et al.
Publicado: (2017) -
Steroid-Free Immune Suppression Impairs Glycemic Control in a Healthy Cynomolgus Monkey
por: Berman, Dora M., et al.
Publicado: (2019) -
4E-BP2/SH2B1/IRS2 Are Part of a Novel Feedback Loop That Controls β-Cell Mass
por: Blandino-Rosano, Manuel, et al.
Publicado: (2016)